Stocksigma LogoStocksigma Logo

Venmax Shareholders Approve Scheme of Amalgamation with Hatri Pharma

Equity shareholders of Venmax Drugs and Pharmaceuticals Limited approved the Scheme of Amalgamation with Hatri Pharma Private Limited during the

Venmax Shareholders Approve Scheme of Amalgamation with Hatri Pharma

Venmax Drugs and Pharmaceuticals Ltd 路 Court Convened Meeting 路 27 Oct 2026, 12:39 am

Venmax Shareholders Approve Scheme of Amalgamation with Hatri Pharma Equity shareholders of Venmax Drugs and Pharmaceuticals Limited approved the Scheme of Amalgamation with Hatri Pharma Private Limited during the NCLT-convened meeting held on 24th Oct'26. The resolution passed with requisite majority, securing 99.9979% overall approval (72,10,542 votes in favor vs. 150 against across 72 voting members). Among public shareholders, votes in favor stood at 99.9976% (62,83,767 votes), comfortably meeting SEBI scheme requirements. Total votes polled represented 62.2527% of the company's 1,15,82,930 paid-up equity shares.

Original exchange filing (PDF)

More announcements from Venmax Drugs and Pharmaceuticals Ltd

All Venmax Drugs and Pharmaceuticals Ltd announcements